1. Repository of OAI
  2. ΑΠΟΘΕΤΗΡΙΟ "ΟΛΥΜΠΙΑΣ"
  3. Σχολή Θετικών Επιστημών
  4. Τμήμα Χημείας
  5. Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά). ΧΗΜ
Ελληνικά   English  
Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/10480
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKalogirou, M.en
dc.contributor.authorTsimihodimos, V.en
dc.contributor.authorGazi, I.en
dc.contributor.authorFilippatos, T.en
dc.contributor.authorSaougos, V.en
dc.contributor.authorTselepis, A. D.en
dc.contributor.authorMikhailidis, D. P.en
dc.contributor.authorElisaf, M.en
dc.date.accessioned2015-11-24T16:56:45Z-
dc.date.available2015-11-24T16:56:45Z-
dc.identifier.issn0300-7995-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/10480-
dc.rightsDefault Licence-
dc.subjectdense high-density lipoprotein (hdl)en
dc.subjectezetimibeen
dc.subjectlipoprotein subfiractionsen
dc.subjectlow-density lipoprotein cholesterol (ldl-c)en
dc.subjectsmall, dense ldlen
dc.subjectlow-density-lipoproteinen
dc.subjectcholesterol absorption inhibitoren
dc.subjectprimary hypercholesterolemiaen
dc.subjectarterial-wallen
dc.subjectmyocardial-infarctionen
dc.subjectmixed hyperlipidemiaen
dc.subjectclinical-practiceen
dc.subjectapolipoprotein-ben
dc.subjectldl-cholesterolen
dc.subjectconsensus-panelen
dc.titleEffect of ezetimibe monotherapy on the concentration of lipoprotein subfractions in patients with primary dyslipidaemiaen
heal.typejournalArticle-
heal.type.enJournal articleen
heal.type.elΆρθρο Περιοδικούel
heal.identifier.primaryDoi 10.1185/030079907x188062-
heal.identifier.secondary<Go to ISI>://000248757500025-
heal.identifier.secondaryhttp://informahealthcare.com/doi/abs/10.1185/030079907X188062-
heal.languageen-
heal.accesscampus-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Θετικών Επιστημών. Τμήμα Χημείαςel
heal.publicationDate2007-
heal.abstractBackground: Recent studies suggest that the distribution of lipoprotein subfractions is an independent predictor of vascular events. Therefore, we evaluated the effect of ezetimibe (a selective cholesterol transport inhibitor) on the concentrations of lipoprotein subfractions in patients with primary dyslipidaemia. Materials and methods: Patients (n = 50) with primary dyslipidaemias were recruited. The concentrations of the individual lipoprotein subfractions were measured using the Lipoprint system at baseline and after 16 weeks of treatment. Results: Ezetimibe reduced total, low-density lipoprotein cholesterol (LDL-C) and non-high-density lipoprotein cholesterol (HDL-C values as well as apolipoprotein B concentrations. Subfractionation of apolipoprotein B-containing lipoproteins showed that the reduction in LDL-C values was due to a fall in the concentrations of all LDL subfractions. However, a more pronounced trend towards a decrease in the concentrations of dense LDL subfractions was observed. Patients with triglyceride values >1.7 mmol/L had significantly greater reductions in the concentrations of small, dense LDL particles compared with those with normal triglyceride levels (49 vs. 19%, respectively; p < 0.05). Ezetimibe decreased the concentrations of HDL-C mainly due to a fall in the concentration of dense HDL subfractions. Conclusion: Ezetimibe can favourably affect the distribution of LDL subfractions, especially in patients with elevated triglyceride values. Further studies are needed to clarify the significance of the ezetimibe-induced reduction in the concentrations of dense HDL particles.en
heal.journalNameCurrent Medical Research and Opinionen
heal.journalTypepeer reviewed-
heal.fullTextAvailabilityTRUE-
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά). ΧΗΜ

Show simple item record
Files in This Item:
There are no files associated with this item.
Show simple item record  


This item is licensed under a Creative Commons License Creative Commons